These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 12029630

  • 21. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F, Pantea L, Sniderman K.
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [Abstract] [Full Text] [Related]

  • 22. Effects of ursodeoxycholic acid on systemic, renal and forearm haemodynamics and sodium homoeostasis in cirrhotic patients with refractory ascites.
    Wong F, Bomzon A, Allard J, Liu P, Blendis L.
    Clin Sci (Lond); 1999 May; 96(5):467-74. PubMed ID: 10209078
    [Abstract] [Full Text] [Related]

  • 23. Role of the renin-angiotensin system in control of sodium excretion and arterial pressure.
    Hall JE, Guyton AC, Mizelle HL.
    Acta Physiol Scand Suppl; 1990 May; 591():48-62. PubMed ID: 2220409
    [Abstract] [Full Text] [Related]

  • 24. Tubular handling of sodium and phosphate in non-ascitic liver cirrhosis.
    Caregaro L, Angeli P, Merlo A, Menon F, Rondana M, Merkel C, Gatta A.
    Scand J Clin Lab Invest; 1987 May; 47(3):247-51. PubMed ID: 3589489
    [Abstract] [Full Text] [Related]

  • 25. [Fluid, electrolyte, and acid-base disorders in liver cirrhosis].
    Kinouchi T.
    Nihon Rinsho; 1994 Jan; 52(1):124-31. PubMed ID: 8114281
    [Abstract] [Full Text] [Related]

  • 26. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria.
    Williams JS, Williams GH, Jeunemaitre X, Hopkins PN, Conlin PR.
    J Hum Hypertens; 2005 Feb; 19(2):133-8. PubMed ID: 15361890
    [Abstract] [Full Text] [Related]

  • 27. Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis.
    Sansoé G, Silvano S, Mengozzi G, Todros L, Smedile A, Touscoz G, Rosina F, Rizzetto M.
    J Hepatol; 2004 Mar; 40(3):417-23. PubMed ID: 15123355
    [Abstract] [Full Text] [Related]

  • 28. [Renal and extra-renal mechanisms of sodium and water retention in cirrhosis with ascites].
    Peña JC.
    Rev Invest Clin; 1995 Mar; 47(1):63-79. PubMed ID: 7777718
    [Abstract] [Full Text] [Related]

  • 29. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
    Wong F, Blei AT, Blendis LM, Thuluvath PJ.
    Hepatology; 2003 Jan; 37(1):182-91. PubMed ID: 12500203
    [Abstract] [Full Text] [Related]

  • 30. Sodium retention in preascitic stage of cirrhosis.
    Magri P, Auletta M, Andreucci M, Somma G, Musone D, Fiorillo M, Torraca S, Antoniello S, Cianciaruso B.
    Semin Nephrol; 2001 May; 21(3):317-22. PubMed ID: 11320501
    [Abstract] [Full Text] [Related]

  • 31. Renal and hemodynamic effects of the peritoneovenous shunt. II. Long-term effects.
    Greig PD, Blendis LM, Langer B, Taylor BR, Colapinto RF.
    Gastroenterology; 1981 Jan; 80(1):119-25. PubMed ID: 7004991
    [Abstract] [Full Text] [Related]

  • 32. Losartan attenuates renal vasoconstriction in response to acute unilateral ureteral occlusion in pigs.
    Hvistendahl JJ, Pedersen TS, Djurhuus JC, Pedersen EB, Frøkiaer J.
    Urol Res; 2002 Jul; 30(3):169-77. PubMed ID: 12111180
    [Abstract] [Full Text] [Related]

  • 33. High plasma cardiac natriuretic peptides associated with enhanced cyclic guanosine monophosphate production in preascitic cirrhosis.
    Iwao T, Oho K, Nakano R, Sakai T, Sato M, Miyamoto Y, Kumamoto M, Sakai K, Sata M, Toyonaga A.
    J Hepatol; 2000 Mar; 32(3):426-33. PubMed ID: 10735612
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pattern of sodium handling and its consequences in patients with preascitic cirrhosis.
    Wong F, Liu P, Allidina Y, Blendis L.
    Gastroenterology; 1995 Jun; 108(6):1820-7. PubMed ID: 7768388
    [Abstract] [Full Text] [Related]

  • 36. Low-dose dopamine infusion in cirrhosis with refractory ascites.
    Lin SM, Lee CS, Kao PF.
    Int J Clin Pract; 1998 Jun; 52(8):533-6. PubMed ID: 10622049
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Interrelationship of renal sodium and phosphate handling in cirrhosis.
    Epstein M, Ramachandran M, DeNunzio AG.
    Miner Electrolyte Metab; 1982 Jun; 7(6):305-15. PubMed ID: 7169992
    [Abstract] [Full Text] [Related]

  • 39. Renal sodium handling and neurohumoral systems in patients with cirrhosis in sitting posture: effects of spironolactone and water immersion.
    Gerbes AL, Pilz A, Wernze H, Jüngst D.
    Clin Investig; 1993 Nov; 71(11):894-7. PubMed ID: 7906160
    [Abstract] [Full Text] [Related]

  • 40. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
    Chamorro V, Wangensteen R, Sainz J, Duarte J, O'Valle F, Osuna A, Vargas F.
    Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.